Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Josue Villegas-Galaviz"'
Publikováno v:
The Journal of Heart and Lung Transplantation. 41:538-549
Heart transplantation (HTx) from hepatitis C virus (HCV)-viremic donors to nonviremic recipients decreases mortality and costs. Consequently, many transplant centers have reported their results using this strategy. Hence, there is a need for an outco
Autor:
Josue Villegas Galaviz, Paul Anaya
Publikováno v:
Journal of the American College of Cardiology. 81:396
Autor:
HUZEFA BHOPALWALA, VINAYAK MISHRA, NAKEYA DEWASWALA, JOSUE VILLEGAS-GALAVIZ, SAMIULLAH ARSHAD, SUBRAMANYA SHYAM GANTI, ADNAN BHOPALWALA, GAURANG VAIDYA
Publikováno v:
Chest. 162:A160-A161
Autor:
Ahmed Noor, Saima Shikari, Nakeya Dewaswala, Josue Villegas-Galaviz, Huzefa Bhopalwala, Andrew Kolodziej, Emma Birks, Navin Rajagopalan, Gaurang N. Vaidya
Publikováno v:
Journal of the American College of Cardiology. 79:2119
Publikováno v:
Journal of the American College of Cardiology. 79:99
Publikováno v:
Journal of the American College of Cardiology. 79:2650
Publikováno v:
Future Cardiology
Introduction: Takotsubo is often described as stress-induced cardiomyopathy and is a known cause of heart failure. Objective: Review the clinical course of a young coronavirus disease 2019 (COVID-19) patient who developed Takotsubo following cardiac
Publikováno v:
Journal of the American College of Cardiology. 77:799
Autor:
Josue Villegas-Galaviz, Maya Guglin
Publikováno v:
Journal of Cardiac Failure. 26:S37
Background The number of patients dying awaiting heart transplantation (HT) can be reduced through HT from Hepatitis C nucleic acid test positive donors (HCV+D) to negative recipients (HCV-R). This strategy remains underused. Objective Analyze the ou